Monoclonal Antibody Offers Significant Protection Against Malaria in Children

A recent study published in the New England Journal of Medicine revealed that the monoclonal antibody L9LS provides up to 77% protection against malaria in children in Mali. With at least 600,000 people dying from malaria annually, this experimental antibody shows promise as a potential alternative to traditional prevention methods. Dr. Trevor Mundel of the Bill and Melinda Gates Foundation emphasized the need for continued innovation in the fight against malaria, highlighting the importance of a comprehensive approach to combat the disease.